Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,813 | 21,688 | 34,392 | 19,602 | 14,311 |
| Marketable Securities | 28,300 | 63,117 | 76,029 | 86,013 | 130,983 |
| Receivables | N/A | 1,863 | 1,774 | 2,551 | 2,405 |
| TOTAL | $97,830 | $91,285 | $117,561 | $111,683 | $153,113 |
| Non-Current Assets | |||||
| PPE Net | 3,660 | 4,092 | 4,511 | 5,015 | 4,961 |
| Investments And Advances | 1,614 | 2,644 | 2,320 | 2,654 | 2,780 |
| Other Non-Current Assets | 10,094 | 9,039 | 9,405 | 9,762 | 10,097 |
| TOTAL | $15,367 | $15,775 | $16,236 | $17,431 | $17,838 |
| Total Assets | $113,197 | $107,060 | $133,797 | $129,114 | $170,951 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,551 | 16,578 | 18,556 | 18,201 | 20,918 |
| Accrued Expenses | 2,022 | 4,497 | 5,500 | 3,023 | 2,365 |
| Other current liabilities | 13,255 | N/A | N/A | N/A | N/A |
| TOTAL | $35,326 | $23,499 | $26,400 | $23,401 | $42,570 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 22 | 22 | 109 |
| Other Non-Current Liabilities | 9,368 | 10,020 | 10,658 | 11,271 | 11,032 |
| TOTAL | $9,368 | $10,020 | $10,658 | $11,271 | $11,032 |
| Total Liabilities | $44,693 | $33,519 | $37,058 | $34,672 | $53,602 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,667 | 26,100 | 25,964 | 25,911 | 23,370 |
| Common Shares | 36 | 26 | 26 | 23 | 23 |
| Retained earnings | -1,730,219 | -1,710,838 | -1,685,672 | -1,653,435 | -1,622,965 |
| Other shareholders' equity | -676 | -623 | -690 | -676 | -663 |
| TOTAL | $68,504 | $73,540 | $96,739 | $94,442 | $117,349 |
| Total Liabilities And Equity | $113,197 | $107,060 | $133,797 | $129,114 | $170,951 |